Neonmind Biosciences Stock Working Capital
| NMDBFDelisted Stock | USD 0.50 0.00 0.00% |
NeonMind Biosciences fundamentals help investors to digest information that contributes to NeonMind Biosciences' financial success or failures. It also enables traders to predict the movement of NeonMind Pink Sheet. The fundamental analysis module provides a way to measure NeonMind Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to NeonMind Biosciences pink sheet.
NeonMind |
NeonMind Biosciences Company Working Capital Analysis
NeonMind Biosciences' Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
CompetitionBased on the company's disclosures, NeonMind Biosciences has a Working Capital of 0.0. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The working capital for all United States stocks is 100.0% higher than that of the company.
NeonMind Working Capital Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses NeonMind Biosciences' direct or indirect competition against its Working Capital to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of NeonMind Biosciences could also be used in its relative valuation, which is a method of valuing NeonMind Biosciences by comparing valuation metrics of similar companies.NeonMind Biosciences is currently under evaluation in working capital category among its peers.
NeonMind Fundamentals
| Return On Equity | -37.22 | |||
| Return On Asset | -1.88 | |||
| Operating Margin | 735.17 % | |||
| Current Valuation | 799.08 K | |||
| Shares Outstanding | 35.82 M | |||
| Price To Book | 12.19 X | |||
| Price To Sales | 18.10 X | |||
| Gross Profit | (84.45 K) | |||
| EBITDA | (6.65 M) | |||
| Net Income | (7.21 M) | |||
| Cash And Equivalents | 89.22 K | |||
| Total Debt | 450.01 K | |||
| Debt To Equity | 1.58 % | |||
| Current Ratio | 0.59 X | |||
| Book Value Per Share | (1.22) X | |||
| Cash Flow From Operations | (5.82 M) | |||
| Earnings Per Share | (0.14) X | |||
| Beta | -1.12 | |||
| Market Capitalization | 272.23 K | |||
| Total Asset | 1.34 M | |||
| Z Score | -13.2 | |||
| Net Asset | 1.34 M |
About NeonMind Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze NeonMind Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of NeonMind Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of NeonMind Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin | |
| ADA | Cardano | |
| XRP | XRP |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Consideration for investing in NeonMind Pink Sheet
If you are still planning to invest in NeonMind Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the NeonMind Biosciences' history and understand the potential risks before investing.
| Transaction History View history of all your transactions and understand their impact on performance | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |